Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Ingevity Corporation is a specialty chemicals business based in the US. Ingevity Corporation shares (NGVT) are listed on the NYSE and all prices are listed in US Dollars. Ingevity Corporation employs 1,850 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$78.99|
|52-week range||$51.46 - $89.55|
|50-day moving average||$74.97|
|200-day moving average||$79.29|
|Wall St. target price||$98.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$5.11|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||1.33%|
|1 month (2021-09-23)||10.94%|
|3 months (2021-07-23)||-1.31%|
|6 months (2021-04-23)||8.26%|
|1 year (2020-10-23)||31.41%|
|2 years (2019-10-23)||-4.47%|
|3 years (2018-10-23)||87.08|
|5 years (2016-10-21)||86.47%|
Valuing Ingevity Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ingevity Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ingevity Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Ingevity Corporation shares trade at around 15x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Ingevity Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.05. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Ingevity Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Ingevity Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $455.5 million.
The EBITDA is a measure of a Ingevity Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.3 billion|
|Operating margin TTM||26.17%|
|Gross profit TTM||$465.5 million|
|Return on assets TTM||9.53%|
|Return on equity TTM||34.49%|
|Market capitalisation||$3.1 billion|
TTM: trailing 12 months
There are currently 777,454 Ingevity Corporation shares held short by investors – that's known as Ingevity Corporation's "short interest". This figure is 7.4% down from 839,333 last month.
There are a few different ways that this level of interest in shorting Ingevity Corporation shares can be evaluated.
Ingevity Corporation's "short interest ratio" (SIR) is the quantity of Ingevity Corporation shares currently shorted divided by the average quantity of Ingevity Corporation shares traded daily (recently around 216561.00278552). Ingevity Corporation's SIR currently stands at 3.59. In other words for every 100,000 Ingevity Corporation shares traded daily on the market, roughly 3590 shares are currently held short.
However Ingevity Corporation's short interest can also be evaluated against the total number of Ingevity Corporation shares, or, against the total number of tradable Ingevity Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ingevity Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Ingevity Corporation shares in existence, roughly 20 shares are currently held short) or 0.0198% of the tradable shares (for every 100,000 tradable Ingevity Corporation shares, roughly 20 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ingevity Corporation.
Find out more about how you can short Ingevity Corporation stock.
We're not expecting Ingevity Corporation to pay a dividend over the next 12 months.
Over the last 12 months, Ingevity Corporation's shares have ranged in value from as little as $51.46 up to $89.55. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Ingevity Corporation's is 2.2153. This would suggest that Ingevity Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia-Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the kraft pulping process and caprolactone monomers. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, coatings, resins, elastomers, bioplastics, medical devices, and other industrial applications. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina.
Everything we know about the Trump Media and Technology Group IPO, plus information on how to buy in.
Steps to owning and managing Valkyrie Bitcoin Strategy ETF units.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Oct. 21, 2021
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.